LeukoSCAN ImmuRAID-MN3 antibody fragment targeting the surface glycoprotein NCA-90 on neutrophils data

Three separate centers involved in a Phase III trial reported results with IMMU's agent versus the standard method of harvesting and labeling the patients' own white cells for re-injection. In 38 patients, true positives were 13 versus eight, true negatives were 19 versus 14, false positives were three versus six, and false negatives were three versus six. It was easier to label and image with the antibody fragment. ...